Mitral Regurgitation

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography

By MedXY 12/01/2025

An international study developed AI-ECG models that diagnose and predict future moderate–severe mitral, tricuspid, and aortic regurgitation, validated across distinct populations and linked to subclinical chamber remodelling.

Cardiology news

Transseptal TMVR with the SAPIEN M3 Lowers 1‑Year Mortality/HF Rehospitalisation in Patients Unsuitable for Surgery or TEER

By MedXY 11/11/2025

A multicountry, single‑arm pivotal trial of the SAPIEN M3 transseptal transcatheter mitral valve replacement (TMVR) in patients deemed unsuitable for surgery or TEER demonstrated a 1‑year composite rate of death or heart‑failure rehospitalisation of 25.2%, significantly below the prespecified 45% performance goal, with few intraprocedural complications.

Cardiology Specialties

Real-World Insights into Clinical Presentation and Outcomes After Mitral Valve Surgery from the MITRACURE Registry

By MedXY 09/07/2025

The MITRACURE registry reveals late-stage referral and suboptimal early intervention in mitral regurgitation surgery, highlighting the need for improved management strategies to enhance repair rates and reduce mortality.

Cardiology Clinical Updates General Surgery news Specialties

Real-World Insights into Clinical Presentation and Surgical Outcomes of Mitral Regurgitation from the MITRACURE Registry

By MedXY 09/06/2025

The MITRACURE international registry reveals that mitral valve surgery patients often present late in disease progression with advanced symptoms, showing modest repair rates and notable in-hospital mortality, underscoring the need for earlier intervention and improved management strategies.